Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.455 USD | -3.36% | -5.74% | -68.84% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.84% | 14.5M | |
-2.00% | 90.27B | |
+1.32% | 40.12B | |
-15.73% | 31.75B | |
+62.93% | 26.6B | |
-21.28% | 14.41B | |
-8.50% | 12.92B | |
-13.06% | 11.44B | |
-44.07% | 11.3B | |
+4.87% | 8.87B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Redhill Biopharma Says FDA Grants 5-Year Market Exclusivity for Bacterial Infection Treatment Talicia, Shares Jump Pre-Bell